-
-
-
-
-
-
-
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Climb Bio names Susan Altschuller as chief financial officer
-
-
-
-
-
-
-
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
-
-
-
-
-
-
-
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
-
-
-
-
-
-
1,160,177 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

